Click here for a confidential contact or call:



Page 8 of 13

Martin Shkreli Sentenced to Seven Years in Prison for Fraud

Posted  03/12/18
By the C|C Whistleblower Lawyer Team The New York Times reported on Friday that Martin Shkreli, the former pharmaceutical executive nicknamed “Pharma Bro” was sentenced to seven years in prison related to his involvement in pharmaceutical company Retrophin and two hedge funds he operated. Shkreli is best known for raising the price of Daraprim, a drug to treat toxoplasmosis, by 5000% in 2015. In August, Shkreli...

United States Targets a Private-Equity Firm and Pharmacy in a Whistleblower Case

Posted  02/26/18
By the C|C Whistleblower Lawyer Team On Friday the Wall Street Journal reported on the U.S. government’s decision to intervene in a False Claims Act qui tam case against pharmacy Diabetic Care Rx LLC and the private equity firm that holds a controlling stake in the pharmacy, Riordan Lewis & Haden Equity Partners (“RLHEP”). Diabetic Care is a compounding pharmacy that mixes different ingredients to create...

Greek Parliament Opens Investigation into Pharmaceutical Bribery

Posted  02/22/18
By the C|C Whistleblower Lawyer Team After twenty hours of debate, the Greek Parliament has approved the creation of a committee to investigate accusations that Novartis, a Swiss pharmaceutical company, bribed at least ten high-level politicians. The investigation will now hold separate and secret votes on whether each of the ten involved politicians should be investigated. The list of politicians includes two...

Fraudster of the Week -- Pharmacy Fraudster Steven Butcher

Posted  02/16/18
By the C|C Whistleblower Lawyer Team On Wednesday, former pharmaceutical sales representative Steven Butcher admitted to running a $45 million scheme to swindle both federally-funded and private health care benefit programs.  Butcher was charged with one count of conspiracy to commit health care fraud and one count of conspiracy to violate the Anti-Kickback Statute, a law designed to remove financial incentives...

Fraudster of the Week -- Former Football Player Monty Grow

Posted  02/9/18
By the C|C Whistleblower Lawyer Team On Monday, a federal jury in Miami unanimously convicted Monty Grow of running a compound pharmaceutical drug conspiracy that bilked $20 million from TRICARE, a healthcare program for military members and their families. Grow was a star linebacker at the University of Florida in the early 1990s and spent two seasons as a cornerback in the NFL. Prosecutors accused Grow of...

Fraudster of the Week -- New Orleans "Pill Mill" Doctor

Posted  02/2/18
By the C|C Whistleblower Lawyer Team A Louisiana federal judge has sentenced Dr. Frederick Floyd to 10 years in prison for operating two New Orleans-based “pill mills.” Last September, Floyd pleaded guilty to dispensing millions of dosages of oxycodone, fentanyl and other addictive drugs to patients. The special agent in charge of the DEA’s New Orleans Field Division noted that Floyd’s “disgraceful...

Tennessee Chiropractor Pays More Than $1.45 Million to Resolve False Claims Act Allegations

Posted  01/26/18
By the C|C Whistleblower Lawyer Team A Lenior City, Tennessee, chiropractor has paid $1.45 million, plus interest, to resolve False Claims Act violations. Matthew Anderson and his management company, PMC LLC, managed four pain clinics in Tennessee, most recently known as; Cookeville Center for Pain Management; Spinal Pain Solutions in Harriman; Preferred Pain Center of Grundy County in Gruetli Laager; and McMinnville...

2017 Whistleblower of the Year Nominee -- Sanofi Aventis

Posted  12/22/17
This "Whistleblower Spotlight" features Sanofi Aventis US, one of our candidates for 2017 Whistleblower of the Year.  The US subsidiary of the French pharmaceutical giant is our only "corporate" candidate for this accolade but represents a growing trend in the whistleblower world of companies saying something when they see something they believe falls outside the realm of business fair play.  In this case, it was...

United Therapeutics Settles FCA Suit for $210M

Posted  12/21/17
United Therapeutics (UT), a Maryland-based pharmaceutical company which produces and distributes drugs for treating pulmonary arterial hypertension, has settled allegations that it illegally paid kickbacks to Medicare patients through its charitable foundation. In its effort to sell more pulmonary arterial hypertension drugs (including Adcirca, Remodulin, Tyvaso, and Orenitram), the company used a non-profit...

Pharmaceutical Rep Whistleblower Warned of the Dangers of Antipsychotic Drug Seroquel

Posted  12/18/17
By the C|C Whistleblower Lawyer Team The Chicago Tribune reports on the story of pharmaceutical sales representative turned whistleblower, Allison Zayas. Zayas worked for pharmaceutical company AstraZeneca marketing and selling the antipsychotic drug Seroquel to doctors and nursing homes. In the winter of 2009, one of Zayas’ clients, a doctor, described to her how a patient died while taking a combination of...
1 5 6 7 8 9 10 11 13